반응형

 

 

Global Data Intelligence Center
구분 보고서 (영문) 업로드
날짜
제약/
바이오/

임상시험
Bio/Pharmaceutical Outsourcing Report, June 2023 06-30-2023
M&A in the Contract Manufacturing Industry Implications and Outlook 2023 06-30-2023
Emerging Market Outsourcing Report Q2, June 2023 06-30-2023
Emerging Markets Contract Service Agreements Q2 2023 07-04-2023
질환별 Atrial Fibrillation Eight-Market Drug Forecast and Market Analysis, June 2023 07-24-2023
Ewing Sarcoma Competitive Landscape, June 2023 07-05-2023
Human Papillomavirus(HPV) Vaccines Competitive Landscape, June 2023 06-30-2023
Rheumatoid Arthritis 68-Market Analysis and Sales Forecast, June 2023 06-27-2023
Rystiggo Approval Brings First Disease Modifying Therapy for MuSK+Myasthenia Gravis, July 2023 07-06-2023
The VPAS fallout continues - Celltrion pulls high-profile biosimilar from the UK market, June 2023 07-03-2023
Unmet Needs Remain in the Treatment of Triple Negative Breast Cancer 07-07-2023
Venous Thromboembolism 68-Market Analysis and Sales Forecast, July 2023 07-06-2023
Venous Thromboembolism (VTE) Epidemiology Forecast to 2032, June 2023 06-28-2023

 

반응형
반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드
날짜
제약/
바이오/
임상시험
Moderna and Merck & Co’s Personalized mRNA Cancer Vaccine Faces Competition from BioNTech and Genentech 05-31-2023
Bio/Pharmaceutical Outsourcing Report, May 2023
05-31-2023
China Dominates CAR-T Therapies
05-30-2023
US Companies Drive 2023 Drug Launches Positioned for Blockbuster Success by 2028
05-30-2023
Clinical Trials: The Impact of COVID-19 and Long COVID
05-30-2023
After 2022 Interest Rate Hikes Spook Investors, Pharma M&A to Resurge in Late 2023
05-26-2023
Johnson & Johnson’s Tremfya Outshines IL-17 Inhibitors as Plaque Psoriasis Treatment
05-25-2023
AbbVie and Genmab’s Bispecific Epkinly Has a First-to-Market Advantage in DLBCL
05-25-2023
Excitement Associated with FDA Approval of Rinvoq in Crohn’s Disease
05-25-2023
Pfizer's Etrasimod Aims to Differentiate UC Market with Strong Safety Profile
05-23-2023
질환별 Dyslipidemia: Epidemiology Forecast to 2032
06-02-2023
Mpox (Monkeypox):  Competitive Landscape
05-31-2023
Reflux Esophagitis (Gastroesophageal Reflux Disease): Competitive Landscape
05-31-2023
Chronic Low Back Pain: Competitive Landscape
05-30-2023
Narcolepsy: Competitive Landscape
05-30-2023
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis – Update
05-30-2023
Ulcerative Colitis: 68-Market Analysis and Sales Forecast
05-23-2023

 

반응형
반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/
임상시험
Oncology Biosimilar Case Studies: Rituximab Biosimilars
05-19-2023
EC’s Proposed Pharma Reforms Spark Industry Discontent
05-19-2023
Cost of Disease-Modifying Therapies for Multiple Sclerosis Continues to Rise in the US
05-18-2023
Market Cap Downturn Hits Over Half of Top 20 
Biopharmaceutical Companies in Q1 2023
05-15-2023
Roche Pays $70 Million for Chinese HER2 Drug That Can 
Cross the Blood-Brain Barrier
05-12-2023
Eisai Joins the ADC Golden Rush
05-12-2023
Novavax Employs AI-Based Dose Selection for
 COVID-Influenza Vaccine Trials
05-12-2023
Farxiga’s Approval for Expanded Use Highlights Potential 
to Differentiate in HF Space
05-12-2023
Encouraging Update from Immatics on TCR-T Therapy for Solid Tumors
05-12-2023
질환별 Top Three Unmet Needs to Target in Parkinson’s Disease
05-23-2023
Multiple Sclerosis: 68-Market Analysis and Sales Forecast
05-23-2023
Myelofibrosis: 68-Market Analysis and Sales Forecast
05-22-2023
Short Bowel Syndrome: Competitive Landscape
05-15-2023
Lewy Body Dementia: Competitive Landscape
05-15-2023
Psoriatic Arthritis: Competitive Landscape
05-15-2023
Osteoarthritis: 68-Market Analysis and Sales Forecast
05-11-2023
반응형
반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드
날짜
제약/
바이오/
임상시험
Thematic Intelligence: Immuno-oncology (2023)
05-10-2023
ImmunoGen’s Drug Elahere Offers Hope for Ovarian Cancer Patients
05-10-2023
Ultragenyx’s Phase I/II Study for mRNA Therapeutic Terminated
05-05-2023
Contract Manufacturing: Opportunities and Threats – April 2023
05-02-2023
April Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q2 2023
05-02-2023
Oncology Drug Sales Expected to Generate $2.2 Trillion by 2029
05-02-2023
Contract Service Agreements – April 2023
05-02-2023
Bio/Pharmaceutical Outsourcing Report, April 2023
04-28-2023
A Broad Range of Unmet Needs Remains in the Immuno-Oncology Space
04-28-2023
APAC Leads in Trials for 2022, with the Majority in Phase II
04-28-2023
Novo Nordisk Blockbuster Ozempic Boasts 23% Sales Surge in 2023
04-28-2023
First Allogeneic Stem Cell Therapy Approval to Pave the Way for Future Therapies in This Class
04-28-2023
질환별 Myocardial Infarction: Competitive Landscape
04-30-2023
Melanoma: Cell & Gene Therapies 15-Market Assessment and Forecast
04-28-2023
Ovarian Cancer: Cell & Gene Therapies 15-Market Assessment and Forecast
04-28-2023

 

반응형

+ Recent posts